Piper Sandler upgraded Celanese to Neutral from Underweight with a price target of $120, up from $105.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CE:
- Celanese in deal with Glaukos for sustained release glaucoma treatment
- George Soros and Steve Cohen Have One Thing in Common: They Both Bet on These 2 Stocks
- Celanese price target raised to $105 from $100 at Piper Sandler
- Celanese resumed with Buy at BofA
- Celanese and Alessa Therapeutics collaborate to advance oncology treatments